These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 8236277)

  • 1. Myeloperoxidase-mediated activation of xenobiotics by human leukocytes.
    Hofstra AH; Uetrecht JP
    Toxicology; 1993 Oct; 82(1-3):221-42. PubMed ID: 8236277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of the human leukocyte enzymes myeloperoxidase and eosinophil peroxidase by dapsone.
    Bozeman PM; Learn DB; Thomas EL
    Biochem Pharmacol; 1992 Aug; 44(3):553-63. PubMed ID: 1324677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of CGS 12094 (prinomide metabolite) to 1,4-benzoquinone by myeloperoxidase: implications for human idiosyncratic agranulocytosis.
    Parrish DD; Schlosser MJ; Kapeghian JC; Traina VM
    Fundam Appl Toxicol; 1997 Feb; 35(2):197-204. PubMed ID: 9038241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of leukocyte-generated reactive metabolites in the pathogenesis of idiosyncratic drug reactions.
    Uetrecht JP
    Drug Metab Rev; 1992; 24(3):299-366. PubMed ID: 1628536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The in vitro effects of Hypericum species on human leukocyte myeloperoxidase activity.
    Pabuçcuoğlu A; Konyalioğlu S; Baş M; Meral GE
    J Ethnopharmacol; 2003 Jul; 87(1):89-92. PubMed ID: 12787959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myeloperoxidase: a leukocyte-derived protagonist of inflammation and cardiovascular disease.
    Nussbaum C; Klinke A; Adam M; Baldus S; Sperandio M
    Antioxid Redox Signal; 2013 Feb; 18(6):692-713. PubMed ID: 22823200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myeloperoxidase and cardiovascular disease.
    Nicholls SJ; Hazen SL
    Arterioscler Thromb Vasc Biol; 2005 Jun; 25(6):1102-11. PubMed ID: 15790935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug metabolism by leukocytes and its role in drug-induced lupus and other idiosyncratic drug reactions.
    Uetrecht J
    Crit Rev Toxicol; 1990; 20(4):213-35. PubMed ID: 2178625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutrophil- and myeloperoxidase-mediated metabolism of reduced nimesulide: evidence for bioactivation.
    Yang M; Chordia MD; Li F; Huang T; Linden J; Macdonald TL
    Chem Res Toxicol; 2010 Nov; 23(11):1691-700. PubMed ID: 20939553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assay of the human leukocyte enzymes myeloperoxidase and eosinophil peroxidase.
    Bozeman PM; Learn DB; Thomas EL
    J Immunol Methods; 1990 Jan; 126(1):125-33. PubMed ID: 2154520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Xenobiotic activation by stimulated human polymorphonuclear leukocytes and myeloperoxidase.
    Eastmond DA; Smith MT
    Methods Enzymol; 1990; 186():579-85. PubMed ID: 2172716
    [No Abstract]   [Full Text] [Related]  

  • 12. Leukocyte myeloperoxidase and salivary lactoperoxidase: identification and quantitation in human mixed saliva.
    Thomas EL; Jefferson MM; Joyner RE; Cook GS; King CC
    J Dent Res; 1994 Feb; 73(2):544-55. PubMed ID: 8120219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative reactivity of the myeloperoxidase-derived oxidants hypochlorous acid and hypothiocyanous acid with human coronary artery endothelial cells.
    Lloyd MM; Grima MA; Rayner BS; Hadfield KA; Davies MJ; Hawkins CL
    Free Radic Biol Med; 2013 Dec; 65():1352-1362. PubMed ID: 24120969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carbamazepine metabolism to a reactive intermediate by the myeloperoxidase system of activated neutrophils.
    Furst SM; Uetrecht JP
    Biochem Pharmacol; 1993 Mar; 45(6):1267-75. PubMed ID: 8385460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carbon monoxide-releasing molecule 3 inhibits myeloperoxidase (MPO) and protects against MPO-induced vascular endothelial cell activation/dysfunction.
    Patterson EK; Fraser DD; Capretta A; Potter RF; Cepinskas G
    Free Radic Biol Med; 2014 May; 70():167-73. PubMed ID: 24583458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolism of isoniazid by activated leukocytes. Possible role in drug-induced lupus.
    Hofstra AH; Li-Muller SM; Uetrecht JP
    Drug Metab Dispos; 1992; 20(2):205-10. PubMed ID: 1352211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of the chlorinating activity of myeloperoxidase by tempol: revisiting the kinetics and mechanisms.
    Queiroz RF; Vaz SM; Augusto O
    Biochem J; 2011 Nov; 439(3):423-31. PubMed ID: 21749327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myeloperoxidase: a target for new drug development?
    Malle E; Furtmüller PG; Sattler W; Obinger C
    Br J Pharmacol; 2007 Nov; 152(6):838-54. PubMed ID: 17592500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolism of drugs by leukocytes.
    Uetrecht JP
    Drug Metabol Drug Interact; 1994; 11(4):259-82. PubMed ID: 12369752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in vivo inhibition of myeloperoxidase with 5-fluorouracil.
    Akbiyik F; Demirpençe E; Kuzu MA; Kilinç K
    Eur J Clin Pharmacol; 2001 Nov; 57(9):631-6. PubMed ID: 11791891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.